about
Novel COL4A1 mutations cause cerebral small vessel disease by haploinsufficiencyGenome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsWhole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C9orf72 as cause of amyotrophic lateral sclerosisGenetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisAssociation scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variantsThe role of the CD58 locus in multiple sclerosisNovel Olig 1-coding variants and susceptibility to multiple sclerosisPolymorphisms in the interferon-gamma/interleukin-26 gene region contribute to sex bias in susceptibility to rheumatoid arthritisNovel polymorphisms in the IL-10 related AK155 gene (chromosome 12q15)Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12.Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival studyTau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouse.Polymorphisms in the GluR2 gene are not associated with amyotrophic lateral sclerosisVariant on 9p21 strongly associates with coronary heart disease, but lacks association with common strokeInterleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis.Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients.Cytokine gene polymorphisms in multifactorial diseases: gateways to novel targets for immunotherapy?Genetic variants are major determinants of CSF antibody levels in multiple sclerosis.Power estimation for non-standardized multisite studiesPrevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort.Progress in multiple sclerosis genetics.Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis.Class II HLA interactions modulate genetic risk for multiple sclerosis.The cellular composition of the human immune system is shaped by age and cohabitation.Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.A second major histocompatibility complex susceptibility locus for multiple sclerosis.Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor.Genetic ablation of IP3 receptor 2 increases cytokines and decreases survival of SOD1G93A mice.No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.Genetic correlation between amyotrophic lateral sclerosis and schizophreniaThe immunogenetic architecture of autoimmune disease.EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans.The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.Inflammatory Gene Expression Profile and Defective Interferon-γ and Granzyme K in Natural Killer Cells From Systemic Juvenile Idiopathic Arthritis Patients.Immunologic profiles of multiple sclerosis treatments reveal shared early B cell alterations.Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation.Rare MEFV variants are not associated with risk to develop multiple sclerosis and severity of disease.TNFRSF1A coding variants in multiple sclerosis.Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.Burden of risk variants correlates with phenotype of multiple sclerosis.
P50
Q24300862-254AE962-1672-4D00-B6FA-8717E6AE494FQ24550675-DB490F76-5CBF-484E-8BA1-69E19C2F9246Q24623830-C41535AB-D263-493A-BF20-6FB1863CC1C1Q24635370-90C28812-5C03-47EE-9976-143DCAB96A4FQ24646663-84D8DE4E-1817-4391-A6FE-3682ED2D3AF9Q24649291-FAA30CFA-34D9-49B4-9AC1-FC6919993400Q24678534-A8A81A92-2CF4-49D5-AA24-F44ADD7C95E1Q28209579-5D3DDA9D-3513-49B7-AB4C-D53ABF609F29Q28214832-3BADD288-1776-4D6C-A2FF-AF745817AF0FQ30410768-797E7E5D-D874-4E78-88D1-FC50F7E9F73EQ33870202-564CCC2B-F39A-4FC5-AC02-FC5C7EA34429Q33899853-EAF9D5B9-3ED8-436F-93ED-E6E9F6D682F2Q34173712-F6192DC2-CAB7-4EB9-9B08-64375234C37DQ34327167-4D764753-EC6E-49C7-849B-F4A33BA93DA3Q34657157-A0FDC447-DDF4-4DED-805E-3459FF23380AQ34778605-E50A79D8-49F1-4115-8725-A6AE588E0FC3Q35161573-E8FC36D2-FC8A-47B4-BCB9-EEA166B8C23FQ35533986-ADCBE0A4-6D64-4029-B29C-13F40D2D23E7Q35978198-AB134378-FA52-498F-957F-413A67BE5B1FQ36226461-9A8A9591-1E36-42F1-886A-BD87B2136F89Q36382352-DFCFFAAF-142E-4174-9493-C16ABBCB97B8Q36866321-F700E305-A06B-4056-BAB0-70CBE7690733Q36920509-BBEC5B68-998C-4846-8771-E36E2AC9260CQ36961446-CB2E1A39-8F19-465F-B23D-045D1D6A5DF6Q37322100-63DD422E-F9AB-4734-A467-85F7DAB5A6F2Q37332571-3379B85A-CE83-484D-8D8A-FDA6396ACF98Q37435432-8A976D5B-85DD-4358-985E-0789642D794CQ37528939-08E36349-F61E-46BF-9EE3-D11FCA2894B7Q37619291-8DCA4AB1-DB37-4F4A-AA15-71F0E9D53377Q37719319-03EA8DF3-4874-45FD-99AB-07F4D523F598Q37989934-965071B8-6B42-4C52-86E7-DA1A1885618AQ38322311-067A89C1-DDEE-4782-BD38-2EEA9475DBEFQ38378476-F08F362B-5771-4F5C-A9C0-DFB6FE433EF8Q38742750-8DFC6842-9A1A-4C3E-B656-69ED1B584A6AQ38861682-35BF081A-66C5-4183-872F-53689AE0E6D3Q40111903-CD54136B-2D0B-4138-8B17-90022A5F30CDQ40260688-45D6EF4D-CE33-4499-A6D3-E6B5CD3AF70AQ40325255-ABB8438B-CF83-4903-8622-81A2908A66FEQ41392222-79701B24-2CE4-42E9-A30F-74D1E28D4ABEQ41757025-4A5D7CE9-8F9E-4282-9289-617A5A7DA1AF
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
An Goris
@ast
An Goris
@en
An Goris
@es
An Goris
@nl
type
label
An Goris
@ast
An Goris
@en
An Goris
@es
An Goris
@nl
prefLabel
An Goris
@ast
An Goris
@en
An Goris
@es
An Goris
@nl
P1053
F-2943-2010
P106
P21
P31
P3829
P4012
P496
0000-0002-1276-6682
P569
2000-01-01T00:00:00Z